Overview
My laboratory utilizes high-throughput single cell sequencing and quantitative imaging technologies, as well as mouse models of metastasis, to mechanistically dissect tumour cell heterogeneity through the lens of tissue regeneration and repair. We are systematically dissecting lineage-specific immune vulnerabilities across epithelial cell states observed in development and cancer progression by combining single cell methods with targeted perturbations. By integrating systems biology methods within a hypothesis driven framework, our goal is to better understand how developmental plasticity amongst individual cancer cells shapes immune susceptibility and lethal transitions like metastasis or the emergence of drug resistance.
Highlights
- 1Nature medicine · 2020
- 2Nature communications · 2021
Publications
Funding
Active
11 grants- PIR01CA282762-02A systems-level approach to therapeutically target STING in cancerNational Cancer Institute · 2025–2030
- KPNSF 231527-01Using generative modeling to understand heterogeneous patterns of cellular communication from scRNA-seq dataNational Science Foundation · 2025–2028
- PIR01CA280572-04Dissecting the impact of tumor-intrinsic chromosomal instability on the cancer ecosystemNational Cancer Institute · 2023–2028
- Sub-PIR01CA280414-04Multi-cellular interactions defining the human brain metastatic nicheNational Cancer Institute · 2023–2028 · via Columbia University
- Co-IR01CA272466-01A1"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"National Cancer Institute · 2023–2028
- PIPSF 253389-01Dissecting the Role of Micronuclei in Tumor EvolutionPershing Square Foundation · 2025–2027
- PIPQSC 243031-01SatSeq: a scalable platform to effectively target multi-modal proteins in cancerPershing Square Sohn Cancer Research Alliance · 2024–2027
- PIBWF 1015818.01Uncovering transcriptional vulnerabilities in latent metastasisBurroughs Wellcome Fund · 2019–2027
- PIR01CA256188-05Probing cytosolic nucleic acid sensing pathways in cancerNational Cancer Institute · 2021–2026
- Co-ISU2C 6352Targeting immune evasion in gastroesophageal cancerStand Up To Cancer · 2023–2026 · via Memorial Sloan Kettering Cancer Center
- Sub-PIMSK 260903-01Dissecting the Role of Micronuclei in Tumor EvolutionPershing Square Foundation · 2025–2026 · via Memorial Sloan Kettering Cancer Center
Completed grants (6)
- PIR21CA266660-01A1Role of the smooth muscle layer in bladder cancer biology and progression: a systems and experimental approachNational Cancer Institute · 2022–2025
- PIAddgene 700481Addgene 700481Addgene, Inc. · 2022–2023
- PIAddgene 699228Addgene 699228Addgene, Inc. · 2022–2023
- PIMRA #622017Dissecting tumor-immune cell interactions in uveal melanomaMelanoma Research Alliance · 2019–2022
- Sub-PIU01CA210152-05Designing an Engineered Environment for Tumor DormancyNational Cancer Institute · 2020–2022 · via The Regents of the University of Michigan
- PILCRF 200973-01Targeting Metastasis-initiating Cells in Lung AdenocarcinomaLung Cancer Research Foundation · 2019–2020
News mentions
- Dr. Ashley Laughney Wins Pershing Square Sohn Prize for Young Investigators in Cancer ResearchJune 17, 2024
Dr. Ashley Laughney, an assistant professor of physiology and biophysics at Weill Cornell Medicine, has won a 2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research.
- How One Type of Lung Cancer Can Transform into AnotherFebruary 8, 2024
Researchers at Weill Cornell Medicine have uncovered steps that lead to lung tumors called adenocarcinoma turning into a much more aggressive small cell lung cancer that spreads rapidly and has few options for treatment. This problematic process is sometimes seen when patients stop responding to initially effective treatments. The findings advance the understanding of how mutated genes can trigger cancer evolution and suggest targets for more effective treatments.
- New Research Shows How Cancer Rewires a Key Immune Pathway To SpreadAugust 23, 2023
A study led by researchers at Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.
Mentoring
PhD · 4
- EKErina KamiyaPhysiology, Biophysics & Systems Biology (PhD) · Class of 2022
- AOAmelia OhnstadCell & Developmental Biology (PhD)
- JZJenny ZhangBiochemistry, Cell & Molecular Biology (PhD)
- RSRebecca SuCell & Developmental Biology (PhD)
Postdoc · 4
- NFNoam FinkelsteinPostdoc mentee · 2022–2022
External relationships
Leadership Roles
Manarola Therapeutics Inc.
Ownership
Manarola Therapeutics Inc.
Professional Services
Manarola Therapeutics Inc.